Caracterización molecular de deleción de IKZF1 y otros genes en niños con Leucemia Linfoblástica Aguda de precursores B
dc.contributor.advisor | Sarmiento Urbina, Isabel Cristina | |
dc.contributor.advisor | Linares Ballesteros, Adriana | |
dc.contributor.advisor | Yunis Hazbun, Luz Karime | |
dc.contributor.author | Martínez Gutiérrez, Cindy Nathalie | |
dc.date.accessioned | 2021-05-13T16:37:46Z | |
dc.date.available | 2021-05-13T16:37:46Z | |
dc.date.issued | 2021-02-28 | |
dc.description.abstract | Las deleciones de IZF1 y algunos otros genes se han asociado con mal pronóstico. Este estudio tiene como objetivo describir la frecuencia de deleciones de IKZF1, CDKN2A, CDKN2B, PAX5, RB1, BTG1, ETV6, EBF1, JAK2, P2RY8, CSF2RA, ILR3A en una cohorte de pacientes pediatricos con diagnóstico de LLA-B en un centro de referencia. Las deleciones se evaluaron mediante técnica de MLPA. Se recolectaron pacientes entre 2018-2020, en total 117 pacientes con diagnóstico de LLA-B en la Fundación Hospital Pediátrico La Misericordia | spa |
dc.description.abstract | Deletions in IKZF1 and other genes have been associated with poor prognosis in pediatric B-cell precursor ALL (BCP-ALL). This study aimed to describe the frequency of IKZF1, CDKN2A, CDKN2B, PAX5, RB1, BTG1, ETV6, EBF1, JAK2, P2RY8, CSF2RA, ILR3A deletions in a cohort of Colombian patients with BCP- ALL. Gene deletions were assessed by multiplex ligation-dependent probe amplification (MLPA), using a commercially available kit (SALSA MLPA P335 ALL-IKZF1 probemix). Between 2018 – 2020, 117 de novo pediatric BCP-ALL patients from Fundación Hospital Pediátrico La Misericordia (Bogotá, Colombia) were enrolled. All the patients were treated according to BFM – ALLIC 2009 protocol. | eng |
dc.description.degreelevel | Especialidades Médicas | spa |
dc.description.researcharea | Oncohematología pediátrica | spa |
dc.format.extent | 1 recurso en línea (30 páginas) | spa |
dc.format.mimetype | application/pdf | spa |
dc.identifier.instname | Universidad Nacional de Colombia | spa |
dc.identifier.reponame | Repositorio Institucional Universidad Nacional de Colombia | spa |
dc.identifier.repourl | https://repositorio.unal.edu.co/ | spa |
dc.identifier.uri | https://repositorio.unal.edu.co/handle/unal/79516 | |
dc.language.iso | spa | spa |
dc.publisher | Universidad Nacional de Colombia | spa |
dc.publisher.branch | Universidad Nacional de Colombia - Sede Bogotá | spa |
dc.publisher.faculty | Facultad de Medicina | spa |
dc.publisher.place | Bogotá | spa |
dc.publisher.program | Bogotá - Medicina - Especialidad en Oncohematología Pediátrica | spa |
dc.relation.references | 1. Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2015;373(16):1541-1552. doi:10.1056/NEJMra1400972 | spa |
dc.relation.references | 2. Acuña L, Sánchez P, Uribe D, Pulido D, Valencia O. Situación Del Cáncer En Colombia 2015.; 2015. Disponible en: https://cuentadealtocosto.org/site/images/Situación del Cancer en Colombia 2015.pdf. | spa |
dc.relation.references | 3. Kato M, Manabe A. Treatment and biology of pediatric acute lymphoblastic leukemia. Pediatr Int. 2018;60(1):4-12. doi:10.1111/ped.13457 | spa |
dc.relation.references | 4. Trujillo AM, Linares Ballesteros A, Sarmiento IC. Intensive chemotherapy in children with acute lymphoblastic leukemia. Interim analysis in a referral center in Colombia. Rev la Fac Med. 2016;64(3):417. doi:10.15446/revfacmed.v64n3.53961 | spa |
dc.relation.references | 5. Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica. 2020;105(11):2524-2539. doi:10.3324/haematol.2020.247031 | spa |
dc.relation.references | 6. Cario G, Leoni V, Conter V, Baruchel A, Schrappe M, Biondi A. BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy. Haematologica. 2020;105(9):2200-2204. doi:10.3324/haematol.2018.207019 | spa |
dc.relation.references | 7. Ueno H, Yoshida K, Shiozawa Y, et al. Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia. Blood Adv. 2020;4(20):5165-5173. doi:10.1182/BLOODADVANCES.2019001307 | spa |
dc.relation.references | 8. Guía de Práctica Clínica para la detección oportuna, diagnóstico y seguimiento de leucemia linfoide aguda y leucemia mieloide aguda en niños, niñas y adolescentes. Ministerio de Salud y Protección Social - Colciencias, Instituto de Evaluación Tecnológica en Salud IETS, Cinets Alianza. Abril de 2013 | spa |
dc.relation.references | 9. Payne KJ, Dovat S. Ikaros and tumor suppression in acute lymphoblastic leukemia. Crit Rev Oncog. 2011;16(1-2):3-12. http://www.ncbi.nlm.nih.gov/pubmed/22150303%0Ahttp://www.pubmedcentral. nih.gov/articlerender.fcgi?artid=PMC3243972. | spa |
dc.relation.references | 10. Tran TH, Harris MH, Nguyen J V., et al. Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia. Blood Adv. 2018;2(5):529-533. doi:10.1182/bloodadvances.2017014704 | spa |
dc.relation.references | 11. Olsson L, Johansson B. Ikaros and leukaemia. Br J Haematol. 2015;169(4):479-491. doi:10.1111/bjh.13342 | spa |
dc.relation.references | 12. Marke R, Van Leeuwen FN, Scheijen B. The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia. Haematologica. 2018;103(4):565-574. doi:10.3324/haematol.2017.185603 | spa |
dc.relation.references | 13. Ayón-Pérez MF, Pimentel-Gutiérrez HJ, Durán-Avelar MDJ, et al. IKZF1 Gene Deletion in Pediatric Patients Diagnosed with Acute Lymphoblastic Leukemia in Mexico. Cytogenet Genome Res. 2019. doi:10.1159/000499641 | spa |
dc.relation.references | 14. Gupta SK, Bakhshi S, Kumar L, Seth R, Kumar R. IKZF1 (IKAROS) deletions in B-ALL 30 and its clinical correlation: A prospective study from a tertiary care centre in Northern India. Leuk Res. 2016;41:7-11. doi:10.1016/j.leukres.2015.07.010 | spa |
dc.relation.references | 15. Ruiz-Delgado GJ, Cantero-Fortiz Y, León-Peña AA, León-González M, Nuñez-Cortés AK, Ruiz-Argüelles GJ. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature. Rev Invest Clin. 2016;68(4):210-214. | spa |
dc.relation.references | 16. Granados-Zamora M, Chaves-Herrera K, Morera-Araya E, et al. IKZF1 deletions as a prognostic factor in costa rican patients with pediatric B-Cell acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2020;42(6):E401-E406. doi:10.1097/MPH.0000000000001807 | spa |
dc.relation.references | 17. Stanulla M, Dagdan E, Zaliova M, et al. IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia. J Clin Oncol. 2018;36(12):1240-1249. doi:10.1200/JCO.2017.74.3617 | spa |
dc.relation.references | 18. Zaliova M, Stuchly J, Winkowska L, et al. Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort. Haematologica. 2019;104(7):1396-1406. doi:10.3324/haematol.2018.204974 | spa |
dc.relation.references | 19. Boer JM, Van Der Veer A, Rizopoulos D, et al. Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: An international collaborative study. Leukemia. 2016;30(1):32-38. doi:10.1038/leu.2015.199 | spa |
dc.relation.references | 20. Gupta SK, Bakhshi S, Kumar L, Kumar V, Kumar R. Gene copy number alteration profile and its clinical correlation in B cell acute lymphoblastic leukemia. Leukemia and Lymphoma. 2017; 58(2):333-342. | spa |
dc.relation.references | 21. Schwab CJ, Chilton L, Morrison H, et al. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: Association with cytogenetics and clinical features. Haematologica. 2013;98(7):1081-1088. doi:10.3324/haematol.2013.085175 | spa |
dc.relation.references | 22. Stanulla M, Cavé H, Moorman A V. IKZF1 deletions in pediatric acute lymphoblastic leukemia: Still a poor prognostic marker? Blood. 2020;135(4):252-260. doi:10.1182/blood.2019000813 | spa |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
dc.rights.license | Atribución-NoComercial-SinDerivadas 4.0 Internacional | spa |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | spa |
dc.subject.ddc | 610 - Medicina y salud::616 - Enfermedades | spa |
dc.subject.decs | Leucemia-Linfoma Linfoblástico de Células Precursoras | |
dc.subject.decs | Precursor Cell Lymphoblastic Leukemia-Lymphoma | |
dc.subject.decs | Pediatría | |
dc.subject.decs | Pediatrics | |
dc.subject.proposal | MLPA | eng |
dc.subject.proposal | Leucemia linfoblástica aguda | spa |
dc.subject.proposal | Deleción IKZF1 | spa |
dc.subject.proposal | Pediatría | spa |
dc.subject.proposal | Filadelfia LIKE | spa |
dc.subject.proposal | acute lymphoblastic leukemia | eng |
dc.subject.proposal | Philadephia like | eng |
dc.subject.proposal | IKZF1 deletions | eng |
dc.subject.proposal | Pediatric leukemia | eng |
dc.title | Caracterización molecular de deleción de IKZF1 y otros genes en niños con Leucemia Linfoblástica Aguda de precursores B | spa |
dc.title.translated | IKZF1 and other genes deletions in patients with pediatric b cell acute lymphoblastic leukemia | eng |
dc.type | Trabajo de grado - Especialidad Médica | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_46ec | spa |
dc.type.coarversion | http://purl.org/coar/version/c_ab4af688f83e57aa | spa |
dc.type.content | Text | spa |
dc.type.driver | info:eu-repo/semantics/masterThesis | spa |
dc.type.redcol | http://purl.org/redcol/resource_type/TM | spa |
dc.type.version | info:eu-repo/semantics/acceptedVersion | spa |
oaire.accessrights | http://purl.org/coar/access_right/c_abf2 | spa |
oaire.fundername | Fundación Hospital Pediátrico La Misericordia | spa |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- IKZF1 documento final 14 febrero 2021.pdf
- Tamaño:
- 715.51 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
- Tesis de Especialidad en Oncohematología pediátrica
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 3.87 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: